These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1280386)

  • 1. Identification of amino acids located in the antibody binding sites of human hepatitis A virus.
    Nainan OV; Brinton MA; Margolis HS
    Virology; 1992 Dec; 191(2):984-7. PubMed ID: 1280386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus.
    Ping LH; Jansen RW; Stapleton JT; Cohen JI; Lemon SM
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8281-5. PubMed ID: 2460866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies.
    Ping LH; Lemon SM
    J Virol; 1992 Apr; 66(4):2208-16. PubMed ID: 1312628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a simian hepatitis A virus (HAV): antigenic and genetic comparison with human HAV.
    Brown EA; Jansen RW; Lemon SM
    J Virol; 1989 Nov; 63(11):4932-7. PubMed ID: 2552172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic epitopes of the hepatitis A virus polyprotein.
    Khudyakov YE; Lopareva EN; Jue DL; Fang S; Spelbring J; Krawczynski K; Margolis HS; Fields HA
    Virology; 1999 Aug; 260(2):260-72. PubMed ID: 10417261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles.
    Stapleton JT; Raina V; Winokur PL; Walters K; Klinzman D; Rosen E; McLinden JH
    J Virol; 1993 Feb; 67(2):1080-5. PubMed ID: 7678298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic diversity of hepatitis A virus in China: VP3-VP1-2A genes and evidence of quasispecies distribution in the isolates.
    Wang H; Zheng H; Cao J; Zhou W; Yi Y; Jia Z; Bi S
    PLoS One; 2013; 8(9):e74752. PubMed ID: 24069343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mimicry of the immunodominant conformation-dependent antigenic site of hepatitis A virus by motifs selected from synthetic peptide libraries.
    Mattioli S; Imberti L; Stellini R; Primi D
    J Virol; 1995 Sep; 69(9):5294-9. PubMed ID: 7543581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing response.
    Gauss-Müller V; Zhou MQ; von der Helm K; Deinhardt F
    J Med Virol; 1990 Aug; 31(4):277-83. PubMed ID: 2176673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis and immunochemical properties of oligopeptides--fragments of capsid proteins of the hepatitis A virus].
    Chikin LD; Kozhich AT; Ivanov VS; Ivanov VT; Nastashenko TA; Kusov IuIu; Balaian MS
    Bioorg Khim; 1991 Jul; 17(7):964-72. PubMed ID: 1724368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the immunogenicity of a synthetic peptide bearing a VP3 epitope of hepatitis A virus.
    Pintó RM; González-Dankaart JF; Sánchez G; Guix S; Gómara MJ; García M; Haro I; Bosch A
    FEBS Lett; 1998 Oct; 438(1-2):106-10. PubMed ID: 9821968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modeling antigenic determinants of the hepatitis A virus using synthetic peptides].
    Kulik LN; Ivanov VS; Chikin LD; Berkova NP; Kozhich AT; Gabriélian AE; Ivanova VT
    Bioorg Khim; 1994 Jul; 20(7):709-19. PubMed ID: 7527634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The synthetic peptide 62-75 VP3 of the hepatitis A virus induces virus-binding antibodies].
    Kusov IuIu; Kazachkov IuA; Dzagurov GK; Nastashenko TA; Kozhich AT; Gabrielian AE; Chikin LD; Ivanov VT; Balaian MS
    Vopr Virusol; 1991; 36(2):114-7. PubMed ID: 1652865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis A virus mutant spectra under the selective pressure of monoclonal antibodies: codon usage constraints limit capsid variability.
    Aragonès L; Bosch A; Pintó RM
    J Virol; 2008 Feb; 82(4):1688-700. PubMed ID: 18057242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of a sequential B-epitope in the VP2 protein of hepatitis A virus.
    Kulik LN; Ivanov VS; Tchikin LD; Ostrovsky AG; Ivanov VT
    FEBS Lett; 1995 Jun; 367(1):85-8. PubMed ID: 7541374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to hepatitis A virus capsid proteins after infection.
    Wang CH; Tschen SY; Heinricy U; Weber M; Flehmig B
    J Clin Microbiol; 1996 Mar; 34(3):707-13. PubMed ID: 8904442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
    Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and antigenicity of chimeric picornaviruses which express hepatitis A virus (HAV) peptide sequences: evidence for a neutralization domain near the amino terminus of VP1 of HAV.
    Lemon SM; Barclay W; Ferguson M; Murphy P; Jing L; Burke K; Wood D; Katrak K; Sangar D; Minor PD
    Virology; 1992 May; 188(1):285-95. PubMed ID: 1314456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analysis of a new hepatitis A virus naturally infecting cynomolgus macaques (Macaca fascicularis).
    Nainan OV; Margolis HS; Robertson BH; Balayan M; Brinton MA
    J Gen Virol; 1991 Jul; 72 ( Pt 7)():1685-9. PubMed ID: 1649902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the location of antigenic sites of swine vesicular disease virus with neutralization-resistant mutants.
    Kanno T; Inoue T; Wang Y; Sarai A; Yamaguchi S
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3099-106. PubMed ID: 8847515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.